Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Hongliu Cai and Kaijin Xu.
Hongliu Cai
Connection Strength
0.665
Kaijin Xu
  1. [Management of COVID-19: the Zhejiang experience]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25; 49(2):147-157.
    View in: PubMed
    Score: 0.221
  2. [Management of corona virus disease-19 (COVID-19): the Zhejiang experience]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21; 49(1):147-157.
    View in: PubMed
    Score: 0.217
  3. Clinical efficacy of methylprednisolone and the combined use of lopinavir/ritonavir with arbidol in treatment of coronavirus disease 2019. J Med Virol. 2021 07; 93(7):4446-4453.
    View in: PubMed
    Score: 0.059
  4. Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trial. Clin Transl Med. 2021 02; 11(2):e297.
    View in: PubMed
    Score: 0.058
  5. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China. Emerg Infect Dis. 2020 06; 26(6):1335-1336.
    View in: PubMed
    Score: 0.055
  6. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020 04 21; 369:m1443.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.